Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Oct;47(8):479-81.
doi: 10.1016/j.aprim.2015.06.004.

[Cost-efficacy of new antiviral treatments for chronic hepatitis C]

[Article in Spanish]
Sabela Lens  1 , Martín Bonacci  2
Affiliations
Editorial

[Cost-efficacy of new antiviral treatments for chronic hepatitis C]

[Article in Spanish]
Sabela Lens et al. Aten Primaria. 2015 Oct.
No abstract available

Keywords: coste; efectividad; hepatitis C; tratamiento antiviral.

PubMed Disclaimer

References

    1. Lens S., Alfaro I. Perspectivas futuras del tratamiento de la hepatitis C, ¿sin interferón y sin ribavirina? Gastroenterol. Hepatol. 2014;37:311–321. - PubMed
    1. Bruguera M., Forns X. Hepatitis C en España. Med. Clin. (Barc). 2006;127:113–117. - PubMed
    1. Westbrook R.H. Natural history of hepatitis C. J. Hepatol. 2014;107:10S–15S.
    1. Razavi H., Waked I., Sarrazin C., Myers R.P., Idilman R., Calinas F. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J. Viral Hepat. 2014;21(Suppl 1):34–59. - PubMed
    1. Yoshida E.M., Sulkowski M.S., Gane E.J., Herring R.W., Ratziu V., Ding X. Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus. Hepatology. 2015;61:41–45. - PubMed

Publication types

MeSH terms

Substances